Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) Shares Outstanding (Weighted Average) (2016 - 2023)

Historic Shares Outstanding (Weighted Average) for Alkermes (ALKS) over the last 14 years, with Q4 2023 value amounting to $166.2 million.

  • Alkermes' Shares Outstanding (Weighted Average) rose 151.52% to $166.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $166.2 million, marking a year-over-year increase of 151.52%. This contributed to the annual value of $166.2 million for FY2023, which is 151.52% up from last year.
  • Per Alkermes' latest filing, its Shares Outstanding (Weighted Average) stood at $166.2 million for Q4 2023, which was up 151.52% from $165.1 million recorded in Q1 2023.
  • In the past 5 years, Alkermes' Shares Outstanding (Weighted Average) registered a high of $166.2 million during Q4 2023, and its lowest value of $156.3 million during Q1 2019.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $160.4 million, with a median of $159.3 million in 2020.
  • Per our database at Business Quant, Alkermes' Shares Outstanding (Weighted Average) soared by 97.35% in 2021 and then soared by 178.47% in 2022.
  • Over the past 5 years, Alkermes' Shares Outstanding (Weighted Average) (Quarter) stood at $157.1 million in 2019, then rose by 1.12% to $158.8 million in 2020, then increased by 1.35% to $160.9 million in 2021, then increased by 1.74% to $163.7 million in 2022, then increased by 1.52% to $166.2 million in 2023.
  • Its Shares Outstanding (Weighted Average) stands at $166.2 million for Q4 2023, versus $165.1 million for Q1 2023 and $163.7 million for Q4 2022.